Ignite Creation Date:
2024-05-06 @ 4:16 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04920708
Status:
RECRUITING
Last Update Posted:
2023-10-27
First Post:
2021-05-27
Brief Title:
Fulvestrant Ipatasertib and CDK46 Inhibition in Metastatic ERHER2- Breast Cancer Patients Without ctDNA Suppression
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Royal Marsden NHS Foundation Trust
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-27
First Submit QC Date:
June 3 2021
Study First Post Date:
2021-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-26
Last Update Post Date:
2023-10-27
Last Update Post Date Type:
ACTUAL